Patents by Inventor Alan O'Connell

Alan O'Connell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of valproic acid analog for the treatment and prevention of migraine and affective illness
    Patent number: 6458840
    Abstract: This invention relates to a method for the treatment and prevention of migraine and affective illness by administering a therapeutically effective amount of the valproic acid analog 2-n-propyl-4-hexynoic acid. The compound 2-n-propyl-4-hexynoic acid is an effective anti-migraine and anti-affective illness drug with greatly reduced adverse effects including neurotoxicity and teratogenic potential compared to valproic acid. This invention thus provides an improved method for treating and preventing migraine and affective illness.
    Type: Grant
    Filed: April 23, 2001
    Date of Patent: October 1, 2002
    Assignee: American Biogenetic Sciences, Inc.
    Inventors: Heinz Nau, Emer Leahy, Alan O'Connell
  • Use of valproic acid analog for the treatment and prevention of migraine and affective illness
    Publication number: 20010031789
    Abstract: This invention relates to a method for the treatment and prevention of migraine and affective illness by administering a therapeutically effective amount of the valproic acid analog 2-n-propyl-4-hexynoic acid. The compound 2-n-propyl-4-hexynoic acid is an effective anti-migraine and anti-affective illness drug with greatly reduced adverse effects including neurotoxicity and teratogenic potential compared to valproic acid. This invention thus provides an improved method for treating and preventing migraine and affective illness.
    Type: Application
    Filed: April 23, 2001
    Publication date: October 18, 2001
    Inventors: Heinz Nau, Emer Leahy, Alan O'Connell
  • Prophylactic or therapeutic agent for amnesia
    Patent number: 6281242
    Abstract: A medicament comprising as an active ingredient a compound represented by the following formula: R2—CH2CONH—R1 wherein R1 represents pyridyl group, a substituted pyridyl group, phenyl group, or a substituted phenyl group; and R2 represents a 2-oxo-1-phyrrolidinyl group which may be substituted (e.g., N-(2,6-dimethylphenyl)-2-(2-oxo-1-pyrrolidinyl)acetamide), which is useful for preventive and/or therapeutic treatment of amnesia caused by, for example, an anesthetic agent for intravenous administration such as propofol.
    Type: Grant
    Filed: June 2, 2000
    Date of Patent: August 28, 2001
    Assignee: Daiichi Pharmaceutical Co., Ltd.
    Inventors: Ciaran Regan, David O'Gorman, Alan O'Connell, Tadashi Shiotani
  • Use of valproic acid analog for the treatment and prevention of migraine and affective illness
    Patent number: 6268396
    Abstract: This invention relates to a method for the treatment and prevention of migraine and affective illness by administering a therapeutically effective amount of the valproic acid analog 2-n-propyl-4-hexynoic acid. The compound 2-n-propyl-4-hexynoic acid is an effective anti-migraine and anti-affective illness drug with greatly reduced adverse effects including neurotoxicity and teratogenic potential compared to valproic acid. This invention thus provides an improved method for treating and preventing migraine and affective illness.
    Type: Grant
    Filed: June 22, 1999
    Date of Patent: July 31, 2001
    Assignee: American Biogenetic Sciences, Inc.
    Inventors: Heinz Nau, Emer Leahy, Alan O'Connell